Augmedix

Augmedix Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Augmedix (AUGX) as of Oct 30, 2026 is 2.86. In the previous year, Financial Leverage (Equity Multiplier) was 22.95 — a change of -87.53% (lower).

Financial Leverage

2.86

YoY

-87.53%

Last updated:

Financial Leverage (Equity Multiplier) of Augmedix is 2023 2.86 . Financial Leverage (Equity Multiplier) of Augmedix was 2022 22.95 . It decreases by -87.53% lower compared to the previous year.

The Augmedix Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
-0.24 USD
Jan 1, 2020
8.94 USD
Jan 1, 2021
2.18 USD
Jan 1, 2022
22.95 USD
Jan 1, 2023
2.86 USD
The Augmedix Financial Leverage history
YEARFinancial LeverageYoY
2.86-87.53%
22.95+951.58%
2.18-75.60%
8.94-3,800.99%
-0.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Augmedix Stock analysis

What does Augmedix do? Augmedix Inc. is a San Francisco-based company specializing in the development of technologies and software to assist medical professionals. It was founded in 2012 by Ian Shakil and Pelu Tran to change the way doctors capture and document patient data. The decision to start Augmedix was influenced by the personal experiences of the two founders. While working in the emergency room, Shakil noticed that he was constantly turning his back on his patients to create medical records, which took away from the actual treatment and interrupted visual contact with the patient. Based on his experiences, he saw an opportunity to help doctors focus more on their patients. Pelu Tran, the other founder, also worked in the healthcare industry and wanted to help doctors and nurses have more time for patient care. Augmedix's business model is based on the integration of speech technology and virtual reality. Augmedix has developed specialized software that directs doctors' attention away from data entry and towards treating their patients. Instead of focusing on writing notes, dictation, and clarifying paper notes, doctors can speak directly to a virtual assistant in real-time, who automates their records and embeds them into their medical records. Through this process automation, doctors can spend more time caring for their patients. Augmedix has now specialized in various areas within medical technology. For example, Augmedix offers speech technology platforms that surgical teams can use to access patient information and follow care protocols during surgery without leaving the operating table. There are also wireless mobile headsets that allow doctors to access patient information and create notes during patient treatment without interrupting contact between the doctor and patient. Augmedix also offers a telemedicine telepresence system that allows doctors and patients to communicate with each other via video calls. The system provides a convenient way for both patients and doctors to conduct and receive video consultations without the need for physical presence. Augmedix has become a major player in the digital healthcare industry, especially for doctors and hospitals. The company has already gained many customers in the US healthcare sector, including dozens of leading clinic chains. With its unique business model, Augmedix has taken a pioneering role in introducing new technologies in healthcare. In collaboration with the cloud computing platform Google Cloud, a dedicated medical security cloud platform and application for the healthcare industry are now being developed. Augmedix and Google Cloud now enable doctors to send medical data in real-time to their Augmedix virtual assistant and simultaneously update existing HIPAA-compliant patient records. Overall, Augmedix has become an important company for the introduction of new technologies in healthcare and can be proud to support doctors in their work and optimize healthcare for patients. Augmedix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Augmedix stock

Financial Leverage (Equity Multiplier) of Augmedix is 2.86 in 2023.

Financial Leverage (Equity Multiplier) of Augmedix changed from 22.95 to 2.86, representing a -87.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Augmedix since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Augmedix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Augmedix

All Key Metrics — Augmedix